輸入代號或公司名稱後按 Enter
1784

訊聯

-0.60 (-1.02%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
58.4038成交張數54.07本益比2.37股價淨值比1.49%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.3977.3%1.140.205.9%1.61%4.59%
2026Q10.25-16.7%0.970.123.9%0.99%3.91%
2025Q40.29-55.4%1.020.154.3%1.16%3.95%
2025Q30.21-10.4%1.380.103.5%0.82%5.56%
2025Q20.22-32.7%1.400.113.8%0.91%5.82%
2025Q10.30-31.6%1.510.155.2%1.16%6.32%
2024Q40.65532.9%1.650.3310.1%2.56%6.64%
2024Q30.23-37.3%1.100.123.8%0.95%4.68%
2024Q20.33-47.8%1.240.175.7%1.43%5.48%
2024Q10.44-4.1%1.540.227.5%1.88%6.92%
2023Q40.10-50.0%1.560.051.8%0.44%6.91%
2023Q30.3721.2%1.660.196.5%1.67%7.61%
2023Q20.63346.9%1.600.3110.6%2.89%7.47%
2023Q10.46389.8%1.110.239.0%2.15%5.20%
2022Q40.210.750.104.0%0.97%3.49%
2022Q30.31200.1%0.490.166.4%1.48%2.32%
2022Q20.14-40.0%0.290.072.9%0.66%1.37%
2022Q10.09-60.0%0.380.052.0%0.42%1.78%
2021Q4-0.05-138.5%0.52-0.02-1.1%-0.22%2.45%
2021Q30.10266.8%0.690.052.4%0.49%3.26%
2021Q20.230.620.124.8%1.09%2.90%
2021Q10.23127.3%0.380.125.1%1.09%1.79%
2020Q40.120.250.062.8%0.57%1.19%
2020Q30.030.120.020.8%0.15%0.57%
2020Q20.000.08-0.00-0.1%-0.01%0.40%
2020Q10.10-38.9%0.070.052.7%0.49%0.31%
2019Q4-0.01-107.2%0.13-0.01-0.3%-0.05%0.63%
2019Q3-0.01-112.5%0.27-0.00-0.1%-0.02%1.31%
2019Q2-0.02-125.0%0.35-0.01-0.5%-0.10%1.67%
2019Q10.17-5.2%0.450.094.7%0.79%2.11%
2018Q40.13598.9%0.460.073.3%0.64%2.18%
2018Q30.070.350.042.1%0.33%1.62%
2018Q20.070.210.042.1%0.36%1.04%
2018Q10.180.080.095.0%0.84%0.42%
2017Q40.02-0.120.010.5%0.09%-0.56%
2017Q3-0.06-0.21-0.03-1.5%-0.24%-1.00%
2017Q2-0.06-0.21-0.03-1.8%-0.26%-1.01%
2017Q1-0.03-174.9%-0.24-0.02-1.0%-0.14%-1.15%
2016Q4-0.07-0.18-0.04-2.4%-0.36%
2016Q3-0.06-0.03-1.5%-0.24%